Surgical Science Sweden AB (publ) (STO:SUS)
38.20
+0.92 (2.47%)
Aug 14, 2026, 5:29 PM CET
STO:SUS Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, STO:SUS stock has a consensus rating of "Strong Buy" and an average price target of kr 57.60. The average 1-year stock price forecast is 50.79% higher than the current stock price, while the lowest is kr 42.00 (+9.95%) and the highest is kr 88.00 (+130.37%).
Price Target: kr 57.60 (+50.79%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for STO:SUS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Berenberg Bank | Berenberg Bank | Buy Upgrades kr 45.00 | Buy | Upgrades | kr 45.00 | +17.80% | Jul 24, 2026 |
Financial Forecast
Revenue This Year
986.87M
from 992.34M
Decreased by -0.55%
Revenue Next Year
1.10B
from 986.87M
Increased by 11.50%
EPS This Year
2.06
from 1.71
Increased by 20.55%
EPS Next Year
2.75
from 2.06
Increased by 33.45%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.